Inventor · disambiguated record
Andrew Mellor
Also filed as: MELLOR ANDREW · MELLOR ANDREW L
14 granted patents·16 pending applications·248 citations·filing 1998–2015
93Inventor score
Files withMED COLLEGE GEORGIA RES INST9MUNN DAVID4LAND INSTR INT LTD2MED COLLEGE OF GEORGIA RES INS2MELLOR ANDREW L2
Top patents by PatentIndex Score
30 records- 0196US6482416B2Regulation of T cell-mediated immunity by tryptophanMED COLLEGE GEORGIA RES INST·Filed 2000·Granted Nov 19, 2002·57 cites·13 claims
- 0289US8232313B2Pharmaceutical compositions containing 1-methyl-D-tryptophanMUNN DAVID·Filed 2008·Granted Jul 31, 2012·14 cites·16 claims
- 0388US7598287B2Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalitiesMED COLLEGE GEORGIA RES INST·Filed 2004·Granted Oct 6, 2009·21 cites·17 claims
- 0488US7422365B2Thermal imaging system and methodLAND INSTR INT LTD·Filed 2004·Granted Sep 9, 2008·56 cites·59 claims
- 0588US6451840B1Regulation of T cell-mediated immunity by tryptophanMED COLLEGE GEORGIA RES INST·Filed 1998·Granted Sep 17, 2002·42 cites·5 claims
- 0687US8580844B2Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalitiesMUNN DAVID·Filed 2009·Granted Nov 12, 2013·4 cites·5 claims
- 0784US7160539B2Regulation of T cell-mediated immunity by tryptophanMEDICAL COLLEGE OF GEORGIA·Filed 2002·Granted Jan 9, 2007·20 cites·10 claims
- 0875US7879791B2Regulation of T cell-mediated immunity by tryptophanMED COLLEGE GEORGIA RES INST·Filed 2006·Granted Feb 1, 2011·3 cites·15 claims
- 0974US8198265B2Regulation of T cell-mediated immunity by tryptophanMUNN DAVID·Filed 2006·Granted Jun 12, 2012·3 cites·7 claims
- 1069US6395876B1High-affinity tryptophan transporterMED COLLEGE GEORGIA RES INST·Filed 1998·Granted May 28, 2002·20 cites·7 claims
- 1168US7465448B2Chemokine receptor antagonists as therapeutic agentsMED COLLEGE GEORGIA RES INST·Filed 2003·Granted Dec 16, 2008·6 cites·5 claims
- 1267US9463239B2Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalitiesGEORGIA REGENTS RES INST INC·Filed 2013·Granted Oct 11, 2016·0 cites·17 claims
- 1367US2009123420A1Regulation of T Cell-Mediated Immunity by D Isomers of Inhibitors of Indoleamine-2,3-DioxygenaseMED COLLEGE GEORGIA RES INST·Filed 2008·Application pending·0 cites
- 1466US7763251B2Kits to assess the risk of tumor progressionMED COLLEGE GEORGIA RES INST·Filed 2006·Granted Jul 27, 2010·0 cites·3 claims
- 1564US2012141998A1Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune toleranceMELLOR ANDREW L·Filed 2012·Application pending·0 cites
- 1663US2013323832A1Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune toleranceGeorgia Health Sciences University·Filed 2013·Application pending·0 cites
- 1761US2012288472A1Regulation of t cell-mediated immunity by tryptophanMUNN DAVID·Filed 2012·Application pending·0 cites
- 1859US2005186289A1Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenaseMED COLLEGE GEORGIA RES INST·Filed 2004·Application pending·0 cites
- 1959US2010267042A1Antigen-Presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune ToleranceMELLOR ANDREW L·Filed 2010·Application pending·0 cites
- 2058US8536514B2Method and apparatus for measuring the temperature of a sheet materialBEYNON THOMAS GEOFFREY RONALD·Filed 2010·Granted Sep 17, 2013·2 cites·46 claims
- 2158US2009155311A1Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cellsMED COLLEGE OF GEORGIA RES INS·Filed 2007·Application pending·0 cites
- 2254US2009297540A1Induction of Indoleamine 2,3-Dioxygenase in Dendritic Cells by TLR Ligands and Uses thereofMELLOR ANDREW·Filed 2006·Application pending·0 cites
- 2353US2012142750A1Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cellsCHEN WEI·Filed 2011·Application pending·0 cites
- 2448US2010055111A1Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cellsMED COLLEGE OF GEORGIA RES INS·Filed 2008·Application pending·0 cites
- 2547US2009041787A1Chemokine receptor antagonists as therapeutic agentsMUNN DAVID H·Filed 2008·Application pending·0 cites
- 2646US2003194803A1Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune toleranceFiled 2002·Application pending·0 cites
- 2744US2014234373A1Methods of Promoting Immune ToleranceGEORGIA REGENTS UNIVERSITY·Filed 2012·Application pending·0 cites
- 2844US2011305713A1Methods and compositions to enhance vaccine efficacy by reprogramming regulatory t cellsMUNN DAVID H·Filed 2011·Application pending·0 cites
- 2940US2010265987A2Method and Apparatus for Measuring the Temperature of a Sheet MaterialLAND INSTR INT LTD·Filed 2008·Application pending·0 cites
- 3035US2017264208A1Improvements in or relating to electrical assemblies for voltage source sub-modulesGENERAL ELECTRIC TECHNOLOGY GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Mellor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →